Drug Profile
Research programme: CD26 antigen inhibitors - America Stem Cell/DARA Biosciences
Alternative Names: Dipeptidyl peptidase IV anatagonists - America Stem Cell/DARA Biosciences; DPP-IV antagonists - America Stem Cell/DARA BiosciencesLatest Information Update: 31 Aug 2012
Price :
$50
*
At a glance
- Originator America Stem Cell; DARA Biosciences
- Developer America Stem Cell; DARA BioSciences
- Class Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Haematological disorders
Most Recent Events
- 31 Aug 2012 Discontinued for Haematological disorders in USA (unspecified route)
- 11 Aug 2009 Early research in Haematological disorders in USA (unspecified route)